10. Commitments and Contingencies (Details Narrative) - Genomas [Member] |
9 Months Ended |
|---|---|
|
Sep. 30, 2016
USD ($)
| |
| Cash paid in acquisition | $ 250,000 |
| Notes payable received in acquisition | $ 1,500,000 |
| Stock ownership | 15.00% |
| Series A Preferred Stock [Member] | |
| Stock received in acquisition | $ 500,000 |
| Series B Preferred Stock [Member] | |
| Stock received in acquisition | $ 345,000 |
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|